Medical technologies
-
RYBREVANT® (amivantamab-vmjw) Provides Higher Activity and Longer Duration of Response When Used in Combination with Lazertinib in Patients with Advanced EGFR-Mutant Non-Small Cell Lung Cancer Who Have Failed Osimertinib
New analysis from CHRYSALIS study presented at the ESMO Annual Congress 2021 supports simultaneously targeting the extracellular and catalytic domains of EGFR -
DePuy Synthes to Showcase Innovation Momentum at the American Academy of Orthopaedic Surgeons (AAOS) Annual Meeting
Differentiated Products and Advancements in Orthopaedic Surgery to be Featured -
DePuy Synthes Introduces the INHANCE™ Shoulder System, a First-to-Market, Fully Integrated Shoulder Arthroplasty System
The INHANCE™ Shoulder System empowers surgeons to treat a broad range of cases with a streamlined, comprehensive implant offering that features common instrumentation and unique interoperative flexibility Designed for hospitals as well as outpatient and ASC settings where economic value and operational efficiency are critical considerations -
Ethicon’s Echelon Circular Powered Stapler Associated With Major Reduction In Serious Complications Following Colorectal Surgery
New Real-World Study Shows 74% Decrease In Anastomotic Leaks Compared To Manual Staplers, Reinforcing Findings From Previous Clinical Studies -
DePuy Synthes Unveils VELYS™ Robotic-Assisted Solution In Australia: The Next Generation Robotic-Assisted Solution For Knee Replacement Surgery Designed For Use With The ATTUNE® Knee System
· Australian orthopaedic surgeons to be among the first in the world to access DePuy Synthes’ VELYS Robotic-Assisted Solution, which has recently been included on the Australian Register of Therapeutic Goods. · VELYS Robotic-Assisted Solution helps address challenges cited with robotic assisted technologies on operational efficiencies by helping to simplify surgeons’ existing workflow.[i],[ii] · A first-of-its-kind mobile training lab will bring innovative training solutions – incorporating virtual reality and novel surgical simulation technologies– enabling surgeons to access training closer to their clinical practice. -
Johnson & Johnson Medical Announces Strategic Partnership With Aussie Startup Navbit To Bring Smartphone-Inspired Tech To Hip Replacement Surgery
· Hip dislocation post hip replacement surgery remains one of the most common causes of revision surgery[i] · Research shows half of acetabular cup implants are unable to achieve their target orientation[ii] due to surgical placement, which can contribute to the risk of hip dislocation,[iii] hip joint wearing out and discomfort[iv] · Johnson & Johnson Medical has entered into an agreement with Navbit to launch Navbit Sprint in Australia - a new navigation system utilising smart sensor technology to assist surgeons in aligning the acetabular cup -
-
Long-Term ERLEADA® (apalutamide) Patient-Reported Outcomes Data in Metastatic Castration-Sensitive Prostate Cancer Demonstrate Maintenance of Health-Related Quality of Life for Patients
Results at ASCO from Phase 3 TITAN study final analysis confirm survival benefit achieved with the addition of ERLEADA® to androgen deprivation therapy without significant side effect burden -
RYBREVANTTM (amivantamab-vmjw) Receives FDA Approval as the First Targeted Treatment for Patients with Non-Small Cell Lung Cancer with EGFR Exon 20 Insertion Mutations
RYBREVANTTM is the first fully-human, bispecific antibody approved in lung cancer Simultaneous FDA approval of a companion diagnostic aids in the identification of exon 20 insertion mutations
